Cancer Research

First Patient Enrolled In Global Phase III Study Of Bevacizumab And Trastuzumab In Early Breast Cancer

PARIS, May 27 /PRNewswire/--- Collaborative groups set out to confirm potential benefits of anticancer therapies to treat women with breast cancer A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BET ...

Article - Anna Ohlden - May 27 2008 - 12:32pm

Estrogen Not Just For Women- It's Implicated In Male Prostate Cancer Also

While estrogen is typically thought of as a "female" hormone, men produce it as well. Researchers say they have pinpointed estrogen as a key player in about half of all prostate cancers. The findings are published in the May 27 online edition of ...

Article - News Staff - May 27 2008 - 9:26pm

Copycat Cell- Polymers Mimic Surface Of The Real Thing

Researchers at The University of Nottingham have taken some important first steps to creating a synthetic copycat of a living cell. Dr Cameron Alexander and PhD student George Pasparakis in the have used polymers — long-chain molecules — to construct capsu ...

Article - News Staff - May 28 2008 - 11:24am

Parents: Quit Smoking And Your Children Are Less Likely To Smoke

LONDON, May 29 /PRNewswire/--- Odds of youth smoking uptake greatly reduced if parents quit If both parents of a child never smoked, research shows that a child's odds of daily smoking are reduced by more than 70 percent(1) compared to when both pare ...

Article - Anna Ohlden - May 28 2008 - 6:32pm

Kiadis Pharma Announces Collaboration With The Julius Maximilians University Of Würzburg, Germany

AMSTERDAM, May 29 /PRNewswire/--- Dr. Mielke Continues his Collaboration With Kiadis Pharma on ATIR(TM) Biopharmaceutical company Kiadis Pharma announces today the clinical development collaboration for its lead product ATIR(TM) with Dr. Stephan Mielke an ...

Article - Anna Ohlden - May 29 2008 - 5:30am

Effective Management Of Breakthrough Pain In Patients With Cancer Using Nycomed's Intranasal Fentanyl Spray

TRONDHEIM, Norway, May 29 /PRNewswire/--- Randomised Double-Blind Trial Results Show Meaningful Pain Relief at 10 Minutes in Patients With Breakthrough Cancer Pain- Treatment Aimed at Opioid-Tolerant Patients With Cancer Experiencing Breakthrough Pain- Ne ...

Article - Anna Ohlden - May 29 2008 - 8:33am

XPD Helicase Implicated In Accelerated Aging Disease

By studying heat-loving microbes, two research teams have gained new insight into how seemingly small differences in a single protein involved in DNA transcription and repair can lead to strikingly different genetic disorders in humans. The two studies in ...

Article - News Staff - May 29 2008 - 12:20pm

First Taxane-Based Non-Anthracycline Containing Chemotherapy In Combination With Herceptin (TCH) For HER2 Positive Early Breast

EDMONTON, Canada, May 29 /PRNewswire/--- TCH (Taxotere, Carboplatin, Herceptin) showed a significant improvement in Disease-Free Survival (DFS) and Overall Survival (OS), compared to AC-T (doxorubicin and cyclophosphamide followed by docetaxel) and a 5-fo ...

Article - Anna Ohlden - May 29 2008 - 4:32pm

Gen-Probe Launches In Europe CE-Marked APTIMA(R) HPV Assay For Detection Of Human Papillomavirus

SAN DIEGO, May 30 /PRNewswire/-- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company has launched in Europe its APTIMA(R) HPV Assay, a highly specific molecular diagnostic test to detect high-risk strains of the human papillomavirus (HP ...

Article - Anna Ohlden - May 30 2008 - 8:32am

Researchers Say PGE2 Is Behind The Puzzling Medical Condition 'Finger Clubbing'

Researchers at the University of Leeds say they have solved a medical condition that puzzled Hippocrates more than 2,000 years ago. The phenomenon of "finger clubbing", a deformity of the fingers and fingernails, has been known for thousands of y ...

Article - News Staff - May 30 2008 - 9:29am